Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has developed a new label-cap combination that protects the integrity of original medicine containers, helping to prevent illegal reuse through clear, irreversible first-opening indication.
Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the pharmaceutical industry, has developed a compact Booklet-Label for a needle protection system used in an international phase III clinical trial conducted by pharmaceutical corporation Sanofi. Comprising over 30 pages, the extensive yet compact booklet contains all required product information in more than 20 languages.
Accuracy, safety, efficiency and speed are essential to the successful performance of clinical trials. Since most studies are conducted internationally, the investigational drugs must be reliably marked and provided with a complete set of information in several languages. For this purpose, Sanofi required a multi-page label making the product information available in many different languages. In addition, the label needed to firmly adhere to the plastic needle protection system without impairing the system’s functionality.
The Booklet-Label developed by Schreiner MediPharm is tightly wrapped around the needle protection system. The compact booklet encompasses 32 pages with medicinal information in 22 languages. It reliably adheres to the plastic substrate of the needle protection system and, due to its flexible material construction of thin booklet paper plus film layers, can be easily wrapped around the quadrangular device. A starter tab makes it possible to easily open and re-close the label.
The Booklet-Label is partially affixed to the device so that the pre-filled syringe and its contents are readily visible after opening. The booklet is equipped with a perforation, allowing for its removal before injection—only a small part of the label which, for instance, may contain variable data, subsequently remains on the device. The label material is suitable for custom overprinting using TTR printers, thus efficiently and flexibly supporting the processes during the clinical trial.
Schreiner MediPharm’s Clinical Trial Supplies (CTS) team is a competence and service partner for clinical trials. The team has comprehensive expertise in the area of Clinical Trial Supplies and provides individual and flexible consulting support to all customers according to their needs. A process center specializing in Booklet-Labels is dedicated to creating reliable solutions that are optimally adapted to the packaging of investigational drugs.
Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, has collaborated with B. Braun Medical Inc., located in Bethlehem, PA, who recently launched its prefilled syringe of Heparin Sodium Injection, USP utilizing Schreiner MediPharm’s label- integrated Needle-Trap system to the U.S. market.
Combined expertise: Schreiner MediPharm and Edelmann Group develop demo version of a smart packaging solution
Schreiner MediPharm has combined its expertise in innovative specialty labels and integrated solutions with folding box manufacturer Edelmann. The result is a smart medicine packaging solution with diverse digital features.
A novel dosing syringe label by Schreiner MediPharm supports reliable and exact dosing of a medicine for children as part of a clinical trial. The specialty label was developed for the syringe system made by Raumedic. It serves as a visual barrier, protecting the adjustment button and prevents healthcare staff from accidently activating the mechanism too early.
Schreiner MediPharm introduces BitSecure Mobile, a digital counterfeiting detection solution
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has introduced BitSecure Mobile, a digital counterfeiting detection solution to help fight illegal trade in counterfeit medicines.
Schreiner MediPharm develops multifunctional covert-hologram seal for tamper protection
Schreiner MediPharm has developed a multifunctional Covert-Hologram Seal that offers reliable first-opening indication and tamper evidence, plus counterfeiting protection. The seal, which features an irreversible, holographic effect, complies with the Falsified Medicines Directive 2011/62/EU that will be enforced from February 2019.
Schreiner MediPharm develops smart blister pack for clinical trial
Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, working in conjunction with the Dutch technology company ECCT (Experts in Communications & Connectivity Technology), has developed a smart blister pack for a global pharmaceutical corporation to enhance medication adherence by clinical trial participants.
Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility
Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.
Schreiner MediPharm develops multi-functional labels for SHL Medical Auto Injectors
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has developed specialty labels for demo devices of various SHL Medical auto injector models in which safety and patient ease of use are paramount. .
Schreiner Medipharm develops innovative label with self-lifting starter tab for small vials
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has introduced a new version of its Pharma-Comb SL (Self-Lifting) label with a special starter tab.
Pharma-Tac Plus Label from Schreiner MediPharm wins first place in North American Tag and Label Manufacturers Institute International Competition
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has been recognized with a first place award for its Pharma-Tac Plus hanging label.
- Nicole Tauster
- Company News
- Created 07 May 2020
- Modified 07 May 2020
- Hits 236